ITRM20120132A1 - Herv-h per l'uso come marcatore molecolare del disturbo dello spettro autistico e relativi metodo diagnostico in vitro, kit diagnostico e usi medici. - Google Patents

Herv-h per l'uso come marcatore molecolare del disturbo dello spettro autistico e relativi metodo diagnostico in vitro, kit diagnostico e usi medici.

Info

Publication number
ITRM20120132A1
ITRM20120132A1 IT000132A ITRM20120132A ITRM20120132A1 IT RM20120132 A1 ITRM20120132 A1 IT RM20120132A1 IT 000132 A IT000132 A IT 000132A IT RM20120132 A ITRM20120132 A IT RM20120132A IT RM20120132 A1 ITRM20120132 A1 IT RM20120132A1
Authority
IT
Italy
Prior art keywords
herv
vitro
molecular marker
medical uses
autistic spectrum
Prior art date
Application number
IT000132A
Other languages
English (en)
Inventor
Emanuela Balestrieri
Paolo Curatolo
Enrico Garaci
Simona Federica Maria Gaudi
Giovanni Rezza
Vallebona Paola Sinibaldi
Original Assignee
Ist Superiore Sanita
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Superiore Sanita filed Critical Ist Superiore Sanita
Priority to IT000132A priority Critical patent/ITRM20120132A1/it
Priority to EP13730073.7A priority patent/EP2834373A1/en
Priority to PCT/IT2013/000094 priority patent/WO2013150555A1/en
Publication of ITRM20120132A1 publication Critical patent/ITRM20120132A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IT000132A 2012-04-02 2012-04-02 Herv-h per l'uso come marcatore molecolare del disturbo dello spettro autistico e relativi metodo diagnostico in vitro, kit diagnostico e usi medici. ITRM20120132A1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT000132A ITRM20120132A1 (it) 2012-04-02 2012-04-02 Herv-h per l'uso come marcatore molecolare del disturbo dello spettro autistico e relativi metodo diagnostico in vitro, kit diagnostico e usi medici.
EP13730073.7A EP2834373A1 (en) 2012-04-02 2013-03-29 Herv-h for use as molecular marker of autistic spectrum disorder and related in vitro diagnostic method, diagnostic kit and medical uses
PCT/IT2013/000094 WO2013150555A1 (en) 2012-04-02 2013-03-29 Herv-h for use as molecular marker of autistic spectrum disorder and related in vitro diagnostic method, diagnostic kit and medical uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000132A ITRM20120132A1 (it) 2012-04-02 2012-04-02 Herv-h per l'uso come marcatore molecolare del disturbo dello spettro autistico e relativi metodo diagnostico in vitro, kit diagnostico e usi medici.

Publications (1)

Publication Number Publication Date
ITRM20120132A1 true ITRM20120132A1 (it) 2013-10-03

Family

ID=46178689

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000132A ITRM20120132A1 (it) 2012-04-02 2012-04-02 Herv-h per l'uso come marcatore molecolare del disturbo dello spettro autistico e relativi metodo diagnostico in vitro, kit diagnostico e usi medici.

Country Status (3)

Country Link
EP (1) EP2834373A1 (it)
IT (1) ITRM20120132A1 (it)
WO (1) WO2013150555A1 (it)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090117562A1 (en) * 2007-04-09 2009-05-07 Valerie Wailin Hu Method and kit for diagnosing Autism using gene expression profiling

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090117562A1 (en) * 2007-04-09 2009-05-07 Valerie Wailin Hu Method and kit for diagnosing Autism using gene expression profiling

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BLOG: "Schizophrenia and suspicious retrovirus", 1 December 2010 (2010-12-01), XP055030649, Retrieved from the Internet <URL:http://bestyoucanbe.blogspot.nl/2010/12/schizoprhenia-and-suspicious-retrovirus.html> [retrieved on 20120621] *
BRUDEK TOMASZ ET AL: "B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity", RETROVIROLOGY, BIOMED CENTRAL LTD., LONDON, GB, vol. 6, no. 1, 16 November 2009 (2009-11-16), pages 104, XP021063717, ISSN: 1742-4690, DOI: 10.1186/1742-4690-6-104 *
EMANUELA BALESTIERI: "Endogenous retroviruses and neuropsychiatric disease: the case of autism", 7 February 2011 (2011-02-07), XP055030652, Retrieved from the Internet <URL:http://www.iss.it/binary/medg/cont/PROGRAMMA.pdf> [retrieved on 20120621] *
K. RUPRECHT ET AL: "Human Endogenous Retrovirus Family HERV-K(HML-2) RNA Transcripts Are Selectively Packaged into Retroviral Particles Produced by the Human Germ Cell Tumor Line Tera-1 and Originate Mainly from a Provirus on Chromosome 22q11.21", JOURNAL OF VIROLOGY, vol. 82, no. 20, 15 October 2008 (2008-10-15), pages 10008 - 10016, XP055030655, ISSN: 0022-538X, DOI: 10.1128/JVI.01016-08 *

Also Published As

Publication number Publication date
EP2834373A1 (en) 2015-02-11
WO2013150555A1 (en) 2013-10-10

Similar Documents

Publication Publication Date Title
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
HUE049886T2 (hu) Tumorspecifikus neoantigéneket tartalmazó készítmények, tumorok kezelésében történõ alkalmazásra
EP2911593A4 (en) PERKUTANE TISSUE ANCHORING TECHNIQUES
EA201270722A1 (ru) Формы рифаксимина и их применение
PL2935303T3 (pl) 4&#39;-fluoronukleozydy, 4&#39;-fluoronukleotydy i ich analogi do leczenia HCV
UY33396A (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
BR112012022879A2 (pt) composto, composição farmacêutica, uso do composto e método de tratamento
BR112015003376A2 (pt) composto ou sal farmaceuticamente aceitável do mesmo , composição farmacêutica e usos de quantidade eficiente
CL2013003450A1 (es) Composicion que contiene oxintomodulina, un polimero de polietilenglicol y 9-fluorenilmetoxicarbonilo o 2-sulfo-9-fluorenilmetoxicarbonilo; metodos de uso.
CL2013002125A1 (es) Compuestos derivados de imidazo[5,1-f][1,2,4]triazinas; composicion farmaceutica; y uso en el tratamiento del deterioro cognitivo asociado con esquizofrenia.
EA201401204A1 (ru) Антитела к il-23p19
BR112012031226A2 (pt) composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
BR112015003259A2 (pt) composto, composição farmacêutica, e, composição de vacina.
IT1395519B1 (it) Pezzo composito, nonche&#39; impiego del pezzo composito
HUE045724T2 (hu) GRPR antagonisták GRPR-pozitív rák kimutatására, diagnózisára és kezelésére
BR112013003530A2 (pt) &#39;&#39;produto farmacêutico, kit, uso e preparações&#39;&#39;
EA201390799A1 (ru) Триазолопиридины
FR2973218B1 (fr) Plaque d&#39;osteosynthese.
CL2012003322A1 (es) Compuestos derivados de benzamida sustituidas; composicion farmacéutica; y uso en el tratamiento del cancer.
IT1398317B1 (it) Nuovo procedimento per la preparazione del dronedarone.
DK2816947T3 (da) Endoskopisk anordning, særlig til medicinsk brug
CL2014001959A1 (es) Compuestos derivados de fenil-1h-imidazo[1,2-b]pirazol sustituidos; procedimiento de preparacion; composicion farmaceutica; y el uso en el tratamiento del cancer.
EP2671913A4 (en) NATURAL RUBBER, RUBBER COMPOSITION THEREOF AND TIRES
EA201491300A1 (ru) Композиция для назального применения с улучшенной стабильностью
BR112013023575A2 (pt) “derivado de octaidrotienoquinolina, composição farmacêutica compreendendo o derivado, e uso destes”